(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

D DRUG DOG

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

D DRUG DOG

ST13

US500000097889211

Class

10

Filing

97889211

Registration

7603960

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

09/06/2025

Classification

Registered

Trademark type

Combined

Nice classes

10

Filing date

04/14/2023

Registration date

12/17/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

09/06/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

New Taipei City, TW

Examiner

PELLETIER II, GEORGE

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "DRUG DOG" in stylized font and, above the wording, an abstract "D"-shaped design containing a profile of a dog face.

Holders and representatives

Holders

Quanta Vision Co., Ltd.

Representatives

M. Scott Alprin ALPRIN LAW OFFICES, P.C.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical diagnostic apparatus for testing for drug metabolites; Medical diagnostic instruments for the analysis of body fluids; Immunoassay analyzers for medical diagnostic use; Medical instrumentsfor analyzing and screening biomarkers in deoxyribonucleic acid (DNA) and ribonucleic acid (RNA); Cholesterol meters; Apparatus for blood analysis; Blood testing apparatus

Publications

History of USPTO decisions and trademark events.

27 publications found

PRA7

REGISTERED - SEC. 7 REQUEST ABANDONED

09/05/2025

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

09/05/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/25/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2025

ES7R

TEAS SECTION 7 REQUEST RECEIVED

02/13/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/29/2024

PUBO

PUBLISHED FOR OPPOSITION

10/29/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/09/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/20/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

09/19/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/19/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

09/19/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/19/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/14/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/14/2024

ALIE

ASSIGNED TO LIE

08/14/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/28/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/12/2024

GNSL

LETTER OF SUSPENSION E-MAILED

01/12/2024

CNSL

SUSPENSION LETTER WRITTEN

01/12/2024

DOCK

ASSIGNED TO EXAMINER

01/10/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/10/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/09/2023

NWAP

NEW APPLICATION ENTERED

04/18/2023

Continuous trademark protection

Get notified about every new filing that threatens D DRUG DOG or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.